Dr. Mostafa Kohif, PharmD, MSc
CEO & Founder
Visionary Driving Innovation in Pharmacogenomics and Precision Medicine
Dr. Kohif, the visionary founder and leader of Kohif PharmaGenix, is driven by a deeply personal mission to revolutionize the field of pharmacogenomics and precision medicine. His passion stems from a heartbreaking experience—the loss of close family members to preventable adverse drug reactions, which could have been avoided with access to personalized medicine. This tragedy ignited Dr. Kohif’s commitment to improving patient care by making pharmacogenomics more accessible, ensuring that no one else would have to suffer the same fate.
As a pioneer in the field, Dr. Kohif’s leadership has been central to shaping the direction of Kohif PharmaGenix. With advanced credentials, including an MSc in Precision Medicine from the University of Florida and certifications in Clinical Pharmacogenomics and Cancer Genomics from Harvard Medical School, Dr. Kohif is uniquely qualified to lead efforts in personalized treatment. His extensive expertise has helped develop cutting-edge, genetically tailored treatment strategies that enhance drug safety and effectiveness, significantly improving patient outcomes.
Beyond his work at Kohif PharmaGenix, Dr. Kohif’s influence extends to healthcare organizations worldwide, where he has played a critical role in integrating pharmacogenomics into routine practice. His dedication to advancing education in precision medicine is further demonstrated by his position as an Adjunct Professor at the University of Florida, where he educates and mentors the next generation of healthcare leaders. Dr. Kohif’s unwavering commitment to innovation continues to drive his mission of transforming healthcare and providing personalized, life-saving care for all.
Dr. Paul J. Sorell, MD
Advisory Board Member
Physician, Technologist, and Pioneer in Precision Medicine
As a contemporary physician who thoroughly understands medicine and technology, I’ve been blessed with practicing at the intersection of these two powerful concepts ever since graduating the NYU Grossman School of Medicine. As a clinician in Physical Medicine & Rehabilitation and life-long “techie”, I was instrumental in the process of transitioning from paper to electronic health records. So with the seeds planted, in 2014, well before “big data” was even a thing, I was one of the first adopters of genetically testing my patients to optimize their medication treatment.
It was thus a natural fit when I was invited to join the advisory board of Kohif PharmaGenix. I’ll be bringing my deep understanding of medicine, years of experience in medical affairs, profound expertise in healthcare communications, and first-hand knowledge of digital health to help build the world leader in pharmacogenomic testing—the premier platform that is both easily implemented and clinically relevant. For, at the end of the day, isn’t that what really matters—improving the lives of those for whom we care?
Dr. Leticia Shea, PharmD, BCACP
Advisory Board Memberr
Advancing Precision Medicine Through Education, Research, and Clinical Expertise
Dr. Leticia Shea is a consultant pharmacist and academic leader with a career spanning clinical practice, scientific communications, and pharmacogenetics education. As a Professor of Pharmacy at Regis University, she has developed innovative pharmacotherapy and pharmacogenetics courses, integrating research and technology to enhance learning and patient care. Dr. Shea’s expertise includes best practices in medication management, precision medicine, pharmacovigilance, and project management, with a proven record of driving process improvements and fostering collaboration among healthcare professionals. Her clinical work at HealthOne Physician Services Group has focused on optimizing medication access, developing clinical decision support tools, and significantly improving medication adherence and safety.
She has authored over 29 peer-reviewed publications and delivered 45 conference presentations, contributing to advancements in medication safety, pharmacogenomics, and health outcomes research. Dr. Shea holds a PharmD from the University of Colorado and an MS in Pharmacogenomics and Precision Medicine from the University of Florida. Her commitment to evidence-based practice and patient-centered care makes her a valued advisor in the evolving field of pharmacogenetics.
Jolene Donald, MSN, APRN, FNP-C, AGACNP-BC, ENP-C
Advisory Board Member
Clinician Leader Uniting Acute Care, Medication Safety, and Genetic Insight
Jolene brings a dynamic frontline perspective to the KOHIF Pharmagenix Advisory Board, drawing from her extensive experience as an Emergency Nurse Practitioner in both urban and rural hospital systems. Board-certified in emergency medicine with dual licensed as a Family Nurse Practitioner and Adult-Gerontology Acute Care Nurse Practitioner, Jolene has firsthand insight into the real-time challenges of medication management in high-acuity settings.
While new to the field of pharmacogenomics, her passion for delivering individualized, evidence-based care aligns seamlessly with Pharmagenix’s mission to optimize therapy through genetic insight. Jolene’s leadership is grounded in a deep commitment to improving patient outcomes, clinical workflow, and provider decision-making, particularly when time and clarity are critical.
Her role on the Advisory Board reflects the company’s dedication to incorporating voices from the bedside into the strategic expansion of PGx in practice. With a strong foundation in acute care and a vision for personalized medicine, Jolene serves as a vital bridge between innovation and clinical reality.
Shaping the Future of Healthcare and Innovation
The dedication and expertise of our leadership team are what drive Kohif Pharmagenix forward. Together, they combine a passion for innovation, excellence, and personalized care, ensuring that we continue to revolutionize patient treatment and contribute meaningfully to the future of healthcare. With a shared commitment to cutting-edge technology, patient-centric solutions, and transformative growth, they are the guiding force behind our company’s success.
We are excited about the future and invite you to join us as we continue to push the boundaries of what’s possible. If you have any questions or would like to learn more, feel free to get in touch with us.